By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Diabetes centre receives global standard accolade

By Editor
13th December 2017
Good practice, Research

A diabetes research centre based in Leicester has officially been recognised for its “high global standards” by an international authority on the condition. 

The Leicester Diabetes Centre (LDC) has been named an ‘International Centre of Excellence’ and an ‘International Centre of Education’ by the International Diabetes Federation (IDF).

The announcement was made during a special ceremony at the IDF 2017 Congress on Tuesday, December 5, in Abu Dhabi.

Professor Kamlesh Khunti, who co-leads the centre along with Professor Melanie Davies CBE, was at the event to hear the announcement.

Professor Khunti, who is also Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, said: “We are hugely honoured to have been named as an International Centre of Excellence and Education.

“It is hugely rewarding to have our hard work recognised and will mean a lot to the rest of the team who work tirelessly all year round.  Through the IDF Centre of Excellence and Education, we will continue to pursue our goals to offer the best available options for rapid, accurate prevention and treatment of Type 2 diabetes.”

Professor Melanie Davies CBE, Professor of Diabetes Medicine at the University of Leicester, said: “Type 2 diabetes represents a significant challenge, but a challenge we are committed to meeting. We are looking forward to working towards sharing solutions and driving positive action on a global scale in a bid to fight the international Type 2 diabetes epidemic.”

Professor Khunti was given the Outstanding Services to Diabetes award during the congress, where he also unveiled the findings of a major European study into diabetes that he chaired.

The report, entitled ‘Integrating Diabetes Evidence into Practice: Challenges and Opportunities to Bridge the Gaps’, involved 38 countries in a bid to find out how and why healthcare systems are failing to control the prevalence of diabetes.

The findings revealed that every year 477,000 people die of diabetes-related complications and treating the condition costs European health services €143 billion annually.

The research was launched because the European arm of the International Diabetes Federation (IDF) wanted to further understand the challenges diabetes still continues to pose across the continent.

Professor Khunti said: “This report has demonstrated there are substantial European-wide challenges in the implementation of evidence-based practice for healthcare systems, healthcare professionals and people living with diabetes.

“We found only 22 (58 per cent) IDF European countries have been implementing national diabetes programmes and only 15 countries (39 per cent) have national diabetes registers, despite urgent recommendations being in place since the 90s.

“As part of our findings, we have published a series of recommendations which we believe are essential to follow if we are to succeed in our global fight for the prevention of Type 2 diabetes.”

Founded in 2012, LDC is responsible for world-leading clinical research, evidence-based education and cutting-edge innovation.

Based at Leicester General Hospital, it is a partnership between Leicester’s Hospitals and the University of Leicester and is now ranked as Europe’s largest diabetes research facility.

The annual four-day congress brought together more than 200 speakers, both world-renowned and newcomers, 230 national diabetes associations from 170 countries and high level participation from the Health Authority Abu Dhabi (HAAD).

To read the report, click here.

Comments (0)

Register an account or login to comment